2011 Scrip Asia 100 - Japan pharma: post-quake analysis
This article was originally published in Scrip
Executive Summary
Recent expansion into international markets and the outsourcing of production to networks of external vendors spared Japanese drugmakers from major earthquake-inflicted disaster, writes Ian Haydock. This article is part of the 2011 Scrip Asia 100.